LABEST 2021 - DAY THREE

- Labest

 LABEST DAY 3 - Thursday, May 27th

 

11:00AM - 11:30AM KEYNOTE ADDRESS  COVID-19 and BEYOND - How to stop a pandemic before it starts

Anne Rimoin Anne Rimoin, Professor, Department of Epidemiology, UCLA Fielding School of Public Health

 

11:30AM - 11:35AM  OPENING REMARKS                                                        

Bill Mitchell William E. (Bill) Mitchell, Founding Partner, Sequel Venture Partners, LLC and Chairman, TDC Board

 

11:35AM - 12:30PM - HOSPITAL CEOS SHARING INNOVATIONS - KITE, A GILEAD COMPANY AUDITORIUM

CEOs of Los Angeles' hospital systems will share their best practices and resulting innovations to address the COVID-19 pandemic and how their collaborative efforts will shape the future of hospital systems and the health of Los Angeles County.

Judy Fortin Moderator: Judy Fortin, Executive Director of Communication, UCLA Health & David Geffen School of Medicine
Johnese Spisso Johnese Spisso, President, UCLA Health, UCLA Hospital System
Jeff Smith Jeff Smith, EVP and COO, Cedars Sinai Health System
Rod Hanners Rod Hanners, CEO, Keck Medicine of USC
Elaine Batchlor Elaine Batchlor, CEO, MLK Community Healthcare

 

12:30PM - 1:15PM - EMERGING THERAPEUTICS IN NEUROSCIENCE - AMGEN AUDITORIUM

Recent advances in neuroscience will be discussed by a panel of experts seeking to impact these frequently unmet medical needs.

Robert Pacifici Moderator: Robert Pacifici, Chief Scientific Officer, CHDI Foundation and TDG Board Member
Daniel Geschwind Dan Geschwind, Gordon and Virginia McDonald Distinguished Professor, Neurology, Psychiatry & Human Genetics, UCLA
Linda Liau Linda Liau, Chair, UCLA Department of Neurosurgery
Richard Ransohoff Richard Ransohoff, Partner, Third Rock Ventures
Greg Rippon Greg Rippon, Vice President, Chief Medical Officer, Neurology, Genentech
Viviana Gradinaru Viviana Gradinaru, Professor of Neuroscience and Biological Engineering, Caltech

 

1:00PM - 1:45PM - SCALING GENE & CELL THERAPIES TO REACH MORE PATIENTS GLOBALLY - KITE, A GILEAD COMPANY AUDITORIUM

Due to a complex, multi-step treatment journey, there are numerous logistical challenges when it comes to expanding the reach of cell and gene therapies. How can we leverage bio manufacturing speed and scale to unlock the potential of cell and gene therapies and ensure they can get to the patients who need them?

Gregory Theyel Moderator: Gregory Theyel, Director, Biomedical Manufacturing Network
Chuck Calderaro Chuck Calderaro, Global Head of Technical Operations, Kite, A Gilead Company
Allison Moore Allison Moore, Chief Technical Officer, Allogene Therapeutics
Joe Gold Joe Gold, Manufacturing Director, Center for Biomedicine at Beckman Research Institute, City of Hope
Robert Deans Robert Deans, Chief Scientific Officer, Synthego

 

1:30PM - 2:15PM - AMGEN VENTURES AND BUSINESS DEVELOPMENT IN LOS ANGELES - AMGEN AUDITORIUM

How much bioscience business development is really happening in Los Angeles?

 

Rajit Malhotra Moderator: Rajit Malhotra, Executive Chairman, Ampersand Biopharmaceuticals, TDG Board Member
Jessica Droge Jessica Droge, Vice President, Business Development, AMGEN
Rachna Khosla Rachna Khosla, Vice President, Business Development, AMGEN
Janis Naeve Janis Naeve, Executive Director, AMGEN
Casey Capparelli Casey Capparelli, Executive Director, Strategy, AMGEN
Carlyn Crisostomo Carlyn Crisostomo, Executive Director, Technology, Strategy & Innovation, AMGEN

 

  AMGEN AUDITORIUM KITE, A GILEAD COMPANY AUDITORIUM
2:30PM - 3:00PM City of Hope Professor Spotlight Presentations USC Professor Spotlight Presentations
3:00PM - 4:00PM  City of Hope Professor Spotlight Lounge Presentation Roundtable USC Professor Spotlight Presentation Roundtable

 

3:00PM - 5:00PM 

TIME TO EXPLORE THE EXHIBITOR BOOTHS, PEARL COHEN POSTER PLAZA, LOUNGE TALKS & JUJAMA NETWORKING